{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:23:02Z","timestamp":1792059782207,"version":"4.4.0"},"reference-count":226,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the mammalian brain, new neurons continue to be generated throughout life in a process known as adult neurogenesis. The role of adult-generated neurons has been broadly studied across laboratories, and mounting evidence suggests a strong link to the HPA axis and concomitant dysregulations in patients diagnosed with mood disorders. Psychedelic compounds, such as phenethylamines, tryptamines, cannabinoids, and a variety of ever-growing chemical categories, have emerged as therapeutic options for neuropsychiatric disorders, while numerous reports link their effects to increased adult neurogenesis. In this systematic review, we examine studies assessing neurogenesis or other neurogenesis-associated brain plasticity after psychedelic interventions and aim to provide a comprehensive picture of how this vast category of compounds regulates the generation of new neurons. We conducted a literature search on PubMed and Science Direct databases, considering all articles published until January 31, 2023, and selected articles containing both the words \u201cneurogenesis\u201d and \u201cpsychedelics\u201d. We analyzed experimental studies using either in vivo or in vitro models, employing classical or atypical psychedelics at all ontogenetic windows, as well as human studies referring to neurogenesis-associated plasticity. Our findings were divided into five main categories of psychedelics: CB1 agonists, NMDA antagonists, harmala alkaloids, tryptamines, and entactogens. We described the outcomes of neurogenesis assessments and investigated related results on the effects of psychedelics on brain plasticity and behavior within our sample. In summary, this review presents an extensive study into how different psychedelics may affect the birth of new neurons and other brain-related processes. Such knowledge may be valuable for future research on novel therapeutic strategies for neuropsychiatric disorders.<\/jats:p>","DOI":"10.1186\/s10020-024-01013-4","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:39:45Z","timestamp":1734590385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review"],"prefix":"10.1186","volume":"30","author":[{"given":"Rafael V.","family":"Lima da Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richardson N.","family":"Le\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago C.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"2","key":"1013_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00213-013-3153-2","volume":"230","author":"L Akinfiresoye","year":"2013","unstructured":"Akinfiresoye L, Tizabi Y. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacology. 2013;230(2):291\u20138. https:\/\/doi.org\/10.1007\/s00213-013-3153-2.","journal-title":"Psychopharmacology"},{"issue":"11","key":"1013_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","volume":"42","author":"LR Aleksandrova","year":"2021","unstructured":"Aleksandrova LR, Phillips AG. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol Sci. 2021;42(11):929\u201342. https:\/\/doi.org\/10.1016\/j.tips.2021.08.003.","journal-title":"Trends Pharmacol Sci"},{"key":"1013_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2007.08.034","author":"KR Alper","year":"2008","unstructured":"Alper KR, Lotsof HS, Kaplan CD. The ibogaine medical subculture. J Ethnopharmacol. 2008. https:\/\/doi.org\/10.1016\/j.jep.2007.08.034.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1013_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/cne.901370404","volume":"137","author":"J Altman","year":"1969","unstructured":"Altman J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol. 1969;137(4):433\u201357. https:\/\/doi.org\/10.1002\/cne.901370404.","journal-title":"J Comp Neurol"},{"issue":"3","key":"1013_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/cne.901240303","volume":"124","author":"J Altman","year":"1965","unstructured":"Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol. 1965;124(3):319\u201335. https:\/\/doi.org\/10.1002\/cne.901240303.","journal-title":"J Comp Neurol"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","volume":"124","author":"A Araque","year":"2017","unstructured":"Araque A, Castillo PE, Manzoni OJ, Tonini R. Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology. 2017;124:13\u201324. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.017.","journal-title":"Neuropharmacology"},{"key":"1013_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-015-1513-x","author":"AM Ara\u00fajo","year":"2015","unstructured":"Ara\u00fajo AM, Carvalho F, Bastos MDL, de Pinho G, P., Carvalho M. The hallucinogenic world of tryptamines: an updated review. Arch Toxicol. 2015. https:\/\/doi.org\/10.1007\/s00204-015-1513-x.","journal-title":"Arch Toxicol"},{"key":"1013_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa193","author":"P Armenian","year":"2020","unstructured":"Armenian P, Rodda LN. Two decades of Ecstasy: shifting demographic trends in decedents using MDMA. J Anal Toxicol. 2020. https:\/\/doi.org\/10.1093\/jat\/bkaa193.","journal-title":"J Anal Toxicol"},{"issue":"6","key":"1013_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1460-9568.2011.07823.x","volume":"34","author":"JM Barker","year":"2011","unstructured":"Barker JM, Boonstra R, Wojtowicz JM. From pattern to purpose: how comparative studies contribute to understanding the function of adult neurogenesis. Eur J Neurosci. 2011;34(6):963\u201377. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07823.x.","journal-title":"Eur J Neurosci"},{"key":"1013_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2011.07851.x","author":"A Barnea","year":"2011","unstructured":"Barnea A, Pravosudov V. Birds as a model to study adult neurogenesis: bridging evolutionary, comparative and neuroethological approaches. Eur J Neurosci. 2011. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07851.x.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1013_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1076\/jhin.12.2.207.15535","volume":"12","author":"AA Baumeister","year":"2003","unstructured":"Baumeister AA, Hawkins MF, Uzelac SM. The myth of Reserpine-Induced Depression: role in the historical development of the Monoamine Hypothesis. J Hist Neurosci. 2003;12(2):207\u201320. https:\/\/doi.org\/10.1076\/jhin.12.2.207.15535.","journal-title":"J Hist Neurosci"},{"issue":"1","key":"1013_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCRESAHA.114.303819","volume":"116","author":"CG Begley","year":"2015","unstructured":"Begley CG, Ioannidis JPA. Reproducibility in Science: improving the standard for basic and preclinical research. Circul Res. 2015;116(1):116\u201326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.303819.","journal-title":"Circul Res"},{"key":"1013_CR13","doi-asserted-by":"publisher","unstructured":"Beiersdorf J, Hevesi Z, Calvigioni D, Pyszkowski J, Romanov R, Szodorai E, Lubec G, Shirran S, Botting CH, Kasper S, Guy GW, Gray R, Marzo V, Di, Harkany T, Keimpema E. Adverse effects of \u22069-tetrahydrocannabinol on neuronal bioenergetics during postnatal development. JCI Insight. 2020;5(23). https:\/\/doi.org\/10.1172\/jci.insight.135418.","DOI":"10.1172\/jci.insight.135418"},{"issue":"7","key":"1013_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41386-018-0013-0","volume":"43","author":"A Belmer","year":"2018","unstructured":"Belmer A, Quentin E, Diaz SL, Guiard BP, Fernandez SP, Doly S, Banas SM, Pitychoutis PM, Moutkine I, Muzerelle A, Tchenio A, Roumier A, Mameli M, Maroteaux L. Positive regulation of raphe serotonin neurons by serotonin 2B receptors. Neuropsychopharmacology. 2018;43(7):1623\u201332. https:\/\/doi.org\/10.1038\/s41386-018-0013-0.","journal-title":"Neuropsychopharmacology"},{"key":"1013_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","volume":"142","author":"SJ Belouin","year":"2018","unstructured":"Belouin SJ, Henningfield JE. Psychedelics: where we are now, why we got here, what we must do. Neuropharmacology. 2018;142:7\u201319. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.018.","journal-title":"Neuropharmacology"},{"issue":"5828","key":"1013_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.1137406","volume":"316","author":"P Berghuis","year":"2007","unstructured":"Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science. 2007;316(5828):1212\u20136. https:\/\/doi.org\/10.1126\/science.1137406.","journal-title":"Science"},{"issue":"4","key":"1013_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134. https:\/\/doi.org\/10.1016\/S0006-3223(99)00230-9.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1013_CR18","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/cercor\/bhy064","volume":"29","author":"C Berthoux","year":"2019","unstructured":"Berthoux C, Barre A, Bockaert J, Marin P, B\u00e9camel C. Sustained activation of postsynaptic 5-HT 2A receptors Gates Plasticity at Prefrontal Cortex synapses. Cereb Cortex. 2019;29(4):1659\u201369. https:\/\/doi.org\/10.1093\/cercor\/bhy064.","journal-title":"Cereb Cortex"},{"key":"1013_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","volume":"227","author":"SA Bonini","year":"2018","unstructured":"Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A. Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol (Vol. 2018;227:300\u201315. https:\/\/doi.org\/10.1016\/j.jep.2018.09.004.","journal-title":"J Ethnopharmacol (Vol"},{"issue":"11","key":"1013_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ph13110334","volume":"13","author":"AM Brito-da-Costa","year":"2020","unstructured":"Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM, Dinis-Oliveira RJ, Madureira-Carvalho \u00c1. Toxicokinetics and toxicodynamics of Ayahuasca alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: clinical and forensic impact. Pharmaceuticals. 2020;13(11):334. https:\/\/doi.org\/10.3390\/ph13110334.","journal-title":"Pharmaceuticals"},{"key":"1013_CR21","doi-asserted-by":"publisher","unstructured":"Browne CA, Lucki I. Antidepressant effects of ketamine: m echanisms underlying fast-acting novel antidepressants. Front Pharmacol. 2013. https:\/\/doi.org\/10.3389\/fphar.2013.00161","DOI":"10.3389\/fphar.2013.00161"},{"key":"1013_CR22","unstructured":"Brunton LL, Chabner BA, Knollmann BC. (2011). Goodman & Gilman\u2019s. In: Shanahan JF, Naglieri C, editors. The pharmacological basis of therapeutics. 12a edition. McGraw - Hill Book Company."},{"issue":"2","key":"1013_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/02791072.2005.10399796","volume":"37","author":"JC Callaway","year":"2005","unstructured":"Callaway JC. Various alkaloid profiles in decoctions of Banisteriopsis Caapi. J Psychoactive Drugs. 2005;37(2):151\u20135. https:\/\/doi.org\/10.1080\/02791072.2005.10399796.","journal-title":"J Psychoactive Drugs"},{"key":"1013_CR24","doi-asserted-by":"publisher","unstructured":"Calvey T, Howells FM. An introduction to psychedelic neuroscience. In: Progress in brain research, 1st edn., Vol. 242, pp. 1\u201323. Elsevier B.V.; 2018. https:\/\/doi.org\/10.1016\/bs.pbr.2018.09.013","DOI":"10.1016\/bs.pbr.2018.09.013"},{"issue":"1","key":"1013_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000356820","volume":"36","author":"JJ Canales","year":"2014","unstructured":"Canales JJ, Ferrer-Donato A. Prenatal exposure to Alcohol and 3,4-Methylenedioxymethamphetamine (ecstasy) alters adult hippocampal neurogenesis and causes Enduring Memory deficits. Dev Neurosci. 2014;36(1):10\u20137. https:\/\/doi.org\/10.1159\/000356820.","journal-title":"Dev Neurosci"},{"key":"1013_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.04.016","author":"TM Carbonaro","year":"2016","unstructured":"Carbonaro TM, Gatch MB. Neuropharmacology of N,N-Dimethyltryptamine. Brain Res Bull. 2016. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.016.","journal-title":"Brain Res Bull"},{"issue":"9","key":"1013_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/0269881117725915","volume":"31","author":"R Carhart-Harris","year":"2017","unstructured":"Carhart-Harris R, Nutt D. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017;31(9):1091\u2013120. https:\/\/doi.org\/10.1177\/0269881117725915.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"1013_CR28","doi-asserted-by":"publisher","first-page":"e0196258","DOI":"10.1371\/journal.pone.0196258","volume":"13","author":"CFD Carneiro","year":"2018","unstructured":"Carneiro CFD, Moulin TC, Macleod MR, Amaral OB. Effect size and statistical power in the rodent fear conditioning literature \u2013 A systematic review. PLoS ONE. 2018;13(4):e0196258. https:\/\/doi.org\/10.1371\/journal.pone.0196258.","journal-title":"PLoS ONE"},{"issue":"1","key":"1013_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2006.08.009","volume":"7","author":"E Castr\u00e9n","year":"2007","unstructured":"Castr\u00e9n E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol. 2007;7(1):18\u201321. https:\/\/doi.org\/10.1016\/j.coph.2006.08.009.","journal-title":"Curr Opin Pharmacol"},{"issue":"1\u20133","key":"1013_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2009.11.017","volume":"628","author":"BJ Catlow","year":"2010","unstructured":"Catlow BJ, Badanich KA, Sponaugle AE, Rowe AR, Song S, Rafalovich I, Sava V, Kirstein CL, Sanchez-Ramos J. Effects of MDMA (ecstasy) during adolescence on place conditioning and hippocampal neurogenesis. Eur J Pharmacol. 2010;628(1\u20133):96\u2013103. https:\/\/doi.org\/10.1016\/j.ejphar.2009.11.017.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1013_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","volume":"228","author":"BJ Catlow","year":"2013","unstructured":"Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J. Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Exp Brain Res. 2013;228(4):481\u201391. https:\/\/doi.org\/10.1007\/s00221-013-3579-0.","journal-title":"Exp Brain Res"},{"issue":"4","key":"1013_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mp.2017.241","volume":"23","author":"L Cavalleri","year":"2018","unstructured":"Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF, Collo G. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling. Mol Psychiatry. 2018;23(4):812\u201323. https:\/\/doi.org\/10.1038\/mp.2017.241.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1013_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/1073858406296601","volume":"13","author":"L Chang","year":"2007","unstructured":"Chang L, Chronicle EP. Functional imaging studies in Cannabis users. Neuroscientist. 2007;13(5):422\u201332. https:\/\/doi.org\/10.1177\/1073858406296601.","journal-title":"Neuroscientist"},{"issue":"3","key":"1013_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/156720510791050948","volume":"7","author":"B Chen","year":"2010","unstructured":"Chen B, Bromley-Brits K, He G, Cai F, Zhang X, Song W. Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimers Disease Mouse Model. Curr Alzheimer Res. 2010;7(3):255\u201361. https:\/\/doi.org\/10.2174\/156720510791050948.","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"1013_CR36","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.neuroscience.2008.04.040","volume":"154","author":"KO Cho","year":"2008","unstructured":"Cho KO, Rhee GS, Kwack SJ, Chung SY, Kim SY. Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus. Neuroscience. 2008;154(3):1034\u201341. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.04.040.","journal-title":"Neuroscience"},{"key":"1013_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hipo.20151","volume":"207","author":"BR Christie","year":"2006","unstructured":"Christie BR, Cameron HA. Neurogenesis in the adult Hippocampus. Eur J Neurosci. 2006;207:199\u2013207. https:\/\/doi.org\/10.1002\/hipo.20151.","journal-title":"Eur J Neurosci"},{"issue":"11","key":"1013_CR38","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ijnp\/pyy057","volume":"21","author":"B Cuccurazzu","year":"2018","unstructured":"Cuccurazzu B, Zamberletti E, Nazzaro C, Prini P, Trusel M, Grilli M, Parolaro D, Tonini R, Rubino T. Adult Cellular neuroadaptations Induced by adolescent THC exposure in female rats are rescued by enhancing Anandamide Signaling. Int J Neuropsychopharmacol. 2018;21(11):1014\u201324. https:\/\/doi.org\/10.1093\/ijnp\/pyy057.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1013_CR124","doi-asserted-by":"publisher","unstructured":"Lima da Cruz RV, Moulin TC, Petiz LL, Le\u00e3o RN. A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus. Front Mol Neurosci. 2018;11. https:\/\/doi.org\/10.3389\/fnmol.2018.00312","DOI":"10.3389\/fnmol.2018.00312"},{"issue":"12","key":"1013_CR39","doi-asserted-by":"publisher","first-page":"e2727","DOI":"10.7717\/peerj.2727","volume":"4","author":"V Dakic","year":"2016","unstructured":"Dakic V, Maciel RdeM, Drummond H, Nascimento JM, Trindade P, Rehen SK. Harmine stimulates proliferation of human neural progenitors. PeerJ. 2016;4(12):e2727. https:\/\/doi.org\/10.7717\/peerj.2727.","journal-title":"PeerJ"},{"key":"1013_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neuropharm.2018.01.005","volume":"142","author":"E Dakwar","year":"2018","unstructured":"Dakwar E, Nunes EV, Hart CL, Hu MC, Foltin RW, Levin FR. A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: results from a randomized, controlled laboratory study. Neuropharmacology. 2018;142:270\u20136. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.005.","journal-title":"Neuropharmacology"},{"key":"1013_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2015.03.011","author":"AL Danforth","year":"2016","unstructured":"Danforth AL, Struble CM, Yazar-Klosinski B, Grob CS. MDMA-assisted therapy: a new treatment model for social anxiety in autistic adults. Prog Neuropsychopharmacol Biol Psychiatry. 2016. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.03.011.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1013_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pnpbp.2016.09.004","volume":"72","author":"J Data-Franco","year":"2017","unstructured":"Data-Franco J, Singh A, Popovic D, Ashton M, Berk M, Vieta E, Figueira ML, Dean OM. Beyond the therapeutic shackles of the monoamines: New mechanisms in bipolar disorder biology. Prog Neuropsychopharmacol Biol Psychiatry. 2017;72:73\u201386. https:\/\/doi.org\/10.1016\/j.pnpbp.2016.09.004.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1013_CR43","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/hbm.21381","volume":"33","author":"DB de Araujo","year":"2012","unstructured":"de Araujo DB, Ribeiro S, Cecchi Ga, Carvalho FM, Sanchez Ta, Pinto JP, de Martinis BS, Crippa Ja, Hallak JEC, Santos AC. Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion. Hum Brain Mapp. 2012;33:2550\u201360. https:\/\/doi.org\/10.1002\/hbm.21381.","journal-title":"Hum Brain Mapp"},{"key":"1013_CR30","doi-asserted-by":"publisher","unstructured":"de Castro-Neto EF, Cunha RH, da, Silveira DX, da, Yonamine M, Gouveia TLF, Cavalheiro EA, Amado D, Naffah-Mazzacoratti M. da G. Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion. World J Biol Chem. 2013;4(4):141. https:\/\/doi.org\/10.4331\/wjbc.v4.i4.141","DOI":"10.4331\/wjbc.v4.i4.141"},{"key":"1013_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agh110","author":"FR de Fonseca","year":"2005","unstructured":"de Fonseca FR, del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol. 2005. https:\/\/doi.org\/10.1093\/alcalc\/agh110.","journal-title":"Alcohol Alcohol"},{"key":"1013_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-4118-4","author":"CM De Freitas","year":"2016","unstructured":"De Freitas CM, Busanello A, Schaffer LF, Peroza LR, Krum BN, Leal CQ, Ceretta APC, Rocha D, J. B. T., Fachinetto R. Behavioral and neurochemical effects induced by reserpine in mice. Psychopharmacology. 2016. https:\/\/doi.org\/10.1007\/s00213-015-4118-4.","journal-title":"Psychopharmacology"},{"key":"1013_CR46","doi-asserted-by":"publisher","unstructured":"de Oliveira Silveira G, dos Santos Guimar\u00e3es, Rebello R, Louren\u00e7o F, Rossi N, Hallak G, J., Yonamine M. Stability evaluation of DMT and harmala alkaloids in ayahuasca tea samples. Molecules. 2020;25(9):2072. https:\/\/doi.org\/10.3390\/molecules25092072","DOI":"10.3390\/molecules25092072"},{"key":"1013_CR47","doi-asserted-by":"publisher","unstructured":"de Vos CMH, Mason NL, Kuypers KPC. Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics. Front Psychiatr. 2021;12(September). https:\/\/doi.org\/10.3389\/fpsyt.2021.724606.","DOI":"10.3389\/fpsyt.2021.724606"},{"issue":"2\u20133","key":"1013_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2010.09.020","volume":"114","author":"T Demirakca","year":"2011","unstructured":"Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Mann K, Hermann D. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2011;114(2\u20133):242\u20135. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.09.020.","journal-title":"Drug Alcohol Depend"},{"key":"1013_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(96)01390-6","author":"C Desmarchelier","year":"1996","unstructured":"Desmarchelier C, Gurni A, Ciccia G, Giulietti AM. Ritual and medicinal plants of the ese\u2019ejas of the amazonian rainforest (Madre De Dios, Per\u00fa). J Ethnopharmacol. 1996. https:\/\/doi.org\/10.1016\/0378-8741(96)01390-6.","journal-title":"J Ethnopharmacol"},{"key":"1013_CR50","doi-asserted-by":"publisher","first-page":"e50326","DOI":"10.3791\/50326","volume":"75","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Miller TM. Direct intraventricular delivery of drugs to the rodent central nervous system. J Visualized Experiments: JoVE. 2013;75:e50326. https:\/\/doi.org\/10.3791\/50326.","journal-title":"J Visualized Experiments: JoVE"},{"issue":"2","key":"1013_CR51","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nchembio.497","volume":"7","author":"BC Dickinson","year":"2011","unstructured":"Dickinson BC, Peltier J, Stone D, Schaffer DV, Chang CJ. Nox2 redox signaling maintains essential cell populations in the brain. Nat Chem Biol. 2011;7(2):106\u201312. https:\/\/doi.org\/10.1038\/nchembio.497.","journal-title":"Nat Chem Biol"},{"issue":"Pt 1","key":"1013_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","volume":"126","author":"E Dom\u00ednguez-Clav\u00e9","year":"2016","unstructured":"Dom\u00ednguez-Clav\u00e9 E, Soler J, Elices M, Pascual JC, \u00c1lvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Res Bull. 2016;126(Pt 1):89\u2013101. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.002.","journal-title":"Brain Res Bull"},{"issue":"3","key":"1013_CR53","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","volume":"113","author":"EF Domino","year":"2010","unstructured":"Domino EF, Warner DS. Taming the ketamine Tiger. Anesthesiology. 2010;113(3):678\u201384. https:\/\/doi.org\/10.1097\/ALN.0b013e3181ed09a2.","journal-title":"Anesthesiology"},{"issue":"1","key":"1013_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2007.07.076","volume":"1175","author":"EJ Downer","year":"2007","unstructured":"Downer EJ, Gowran A, Campbell VA. A comparison of the apoptotic effect of \u22069-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex. Brain Res. 2007;1175(1):39\u201347. https:\/\/doi.org\/10.1016\/j.brainres.2007.07.076.","journal-title":"Brain Res"},{"issue":"12","key":"1013_CR55","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1101\/lm.026542.112","volume":"20","author":"LJ Drew","year":"2013","unstructured":"Drew LJ, Fusi S, Hen R. Adult neurogenesis in the mammalian hippocampus: why the dentate gyrus? Learn Memory (Cold Spring Harbor N Y). 2013;20(12):710\u201329. https:\/\/doi.org\/10.1101\/lm.026542.112.","journal-title":"Learn Memory (Cold Spring Harbor N Y)"},{"issue":"1601","key":"1013_CR56","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","volume":"367","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Trans Royal Soc B: Biol Sci (Vol. 2012;367(1601):2475\u201384. https:\/\/doi.org\/10.1098\/rstb.2011.0357.","journal-title":"Philosophical Trans Royal Soc B: Biol Sci (Vol"},{"issue":"2","key":"1013_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S1461145712000545","volume":"16","author":"WC Duncan","year":"2013","unstructured":"Duncan WC, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, Yuan P, Brutsche N, Manji HK, Tononi G, Zarate CA. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. Int J Neuropsychopharmacol. 2013;16(2):301\u201311. https:\/\/doi.org\/10.1017\/S1461145712000545.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"1013_CR58","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1021\/acs.jmedchem.9b01404","volume":"63","author":"LE Dunlap","year":"2020","unstructured":"Dunlap LE, Azinfar A, Ly C, Cameron LP, Viswanathan J, Tombari RJ, Myers-Turnbull D, Taylor JC, Grodzki AC, Lein PJ, Kokel D, Olson DE. Identification of psychoplastogenic N, N -Dimethylaminoisotryptamine (isoDMT) analogues through structure\u2013activity relationship studies. J Med Chem. 2020;63(3):1142\u201355. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01404.","journal-title":"J Med Chem"},{"key":"1013_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.877321","author":"A Emerson","year":"2014","unstructured":"Emerson A, Pont\u00e9 L, Jerome L, Doblin R. History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS). J Psychoactive Drugs. 2014. https:\/\/doi.org\/10.1080\/02791072.2014.877321.","journal-title":"J Psychoactive Drugs"},{"key":"1013_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/3305","author":"PS Eriksson","year":"1998","unstructured":"Eriksson PS, Perfilieva E, Bj\u00f6rk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med. 1998. https:\/\/doi.org\/10.1038\/3305.","journal-title":"Nat Med"},{"issue":"8","key":"1013_CR61","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/0006-2952(86)90285-6","volume":"35","author":"I Fagervall","year":"1986","unstructured":"Fagervall I, Ross SB. Inhibition of mono amine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Biochem Pharmacol. 1986;35(8):1381\u20137. https:\/\/doi.org\/10.1016\/0006-2952(86)90285-6.","journal-title":"Biochem Pharmacol"},{"issue":"1\u20133","key":"1013_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.schres.2015.11.006","volume":"169","author":"N Fan","year":"2015","unstructured":"Fan N, Luo Y, Xu K, Zhang M, Ke X, Huang X, Ding Y, Wang D, Ning Y, Deng X, He H. Relationship of serum levels of TNF-\u03b1, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers. Schizophr Res. 2015;169(1\u20133):10\u20135. https:\/\/doi.org\/10.1016\/j.schres.2015.11.006.","journal-title":"Schizophr Res"},{"key":"1013_CR63","doi-asserted-by":"publisher","unstructured":"Feduccia AA, Mithoefer MC. (2018). MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms? In Progress in Neuro-Psychopharmacology and Biological Psychiatry. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.03.003","DOI":"10.1016\/j.pnpbp.2018.03.003"},{"issue":"2","key":"1013_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1570159x17666190903103923","volume":"18","author":"SG Ferber","year":"2019","unstructured":"Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, Shbiro L, Weller A. The entourage effect: terpenes coupled with cannabinoids for the treatment of Mood disorders and anxiety disorders. Curr Neuropharmacol. 2019;18(2):87\u201396. https:\/\/doi.org\/10.2174\/1570159x17666190903103923.","journal-title":"Curr Neuropharmacol"},{"key":"1013_CR65","doi-asserted-by":"publisher","unstructured":"Ferraz CAA, de Oliveira J\u00fanior RG, Picot L, da Silva Almeida JRG, Nunes XP. Pre-clinical investigations of \u03b2-carboline alkaloids as antidepressant agents: a systematic review. Fitoterapia. 2019;137(March). https:\/\/doi.org\/10.1016\/j.fitote.2019.104196.","DOI":"10.1016\/j.fitote.2019.104196"},{"issue":"8","key":"1013_CR68","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.pnpbp.2009.07.021","volume":"33","author":"JJ Fortunato","year":"2009","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, Pinto JP, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1425\u201330. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.07.021.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"1013_CR66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00702-010-0451-2","volume":"117","author":"JJ Fortunato","year":"2010","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. J Neural Transm. 2010a;117(10):1131\u20137. https:\/\/doi.org\/10.1007\/s00702-010-0451-2.","journal-title":"J Neural Transm"},{"issue":"4\u20135","key":"1013_CR67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.brainresbull.2009.09.008","volume":"81","author":"JJ Fortunato","year":"2010","unstructured":"Fortunato JJ, R\u00e9us GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Effects of \u03b2-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: further evidence of antidepressant properties. Brain Res Bull. 2010b;81(4\u20135):491\u20136. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.09.008.","journal-title":"Brain Res Bull"},{"issue":"9","key":"1013_CR70","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","volume":"120","author":"E Frecska","year":"2013","unstructured":"Frecska E, Szabo A, Winkelman MJ, Luna LE, McKenna DJ. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transmission (Vienna Austria: 1996). 2013;120(9):1295\u2013303. https:\/\/doi.org\/10.1007\/s00702-013-1024-y.","journal-title":"J Neural Transmission (Vienna Austria: 1996)"},{"issue":"March","key":"1013_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2016.00035","volume":"7","author":"E Frecska","year":"2016","unstructured":"Frecska E, Bokor P, Winkelman M. The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization. Front Pharmacol. 2016;7(March):1\u201317. https:\/\/doi.org\/10.3389\/fphar.2016.00035.","journal-title":"Front Pharmacol"},{"key":"1013_CR71","doi-asserted-by":"publisher","DOI":"10.1056\/nejm195412162512504","author":"ED Freis","year":"1954","unstructured":"Freis ED. Mental Depression in Hypertensive patients treated for long periods with large doses of Reserpine. N Engl J Med. 1954. https:\/\/doi.org\/10.1056\/nejm195412162512504.","journal-title":"N Engl J Med"},{"issue":"1","key":"1013_CR72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1073\/pnas.1814709116","volume":"116","author":"K Fukumoto","year":"2019","unstructured":"Fukumoto K, Foga\u00e7a MV, Liu R-J, Duman C, Kato T, Li X-Y, Duman RS. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 R,6 R)-hydroxynorketamine. Proc Natl Acad Sci. 2019;116(1):297\u2013302. https:\/\/doi.org\/10.1073\/pnas.1814709116.","journal-title":"Proc Natl Acad Sci"},{"issue":"August 2020","key":"1013_CR73","doi-asserted-by":"publisher","first-page":"110096","DOI":"10.1016\/j.pnpbp.2020.110096","volume":"106","author":"R Garani","year":"2021","unstructured":"Garani R, Watts JJ, Mizrahi R. Endocannabinoid system in psychotic and mood disorders, a review of human studies. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106(August 2020):110096. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110096.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1013_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuro.2016.06.014","volume":"56","author":"R Garc\u00eda-Cabrerizo","year":"2016","unstructured":"Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ. Comparative effects of amphetamine-like psychostimulants on rat hippocampal cell genesis at different developmental ages. Neurotoxicology. 2016;56:29\u201339. https:\/\/doi.org\/10.1016\/j.neuro.2016.06.014.","journal-title":"Neurotoxicology"},{"key":"1013_CR75","doi-asserted-by":"publisher","unstructured":"Geyer MA, Nichols DE, Vollenweider FX. Serotonin-related psychedelic drugs. In: Encyclopedia of neuroscience. Elsevier. 2009; pp. 731\u2013738. https:\/\/doi.org\/10.1016\/B978-008045046-9.01160-8","DOI":"10.1016\/B978-008045046-9.01160-8"},{"issue":"4","key":"1013_CR76","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroscience.2010.03.032","volume":"167","author":"BK Goulart","year":"2010","unstructured":"Goulart BK, de Lima MNM, de Farias CB, Reolon GK, Almeida VR, Quevedo J, Kapczinski F, Schr\u00f6der N, Roesler R. Ketamine impairs recognition memory consolidation and prevents learning-induced increase in hippocampal brain-derived neurotrophic factor levels. Neuroscience. 2010;167(4):969\u201373. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.03.032.","journal-title":"Neuroscience"},{"key":"1013_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-02211-6","author":"F Graham","year":"2023","unstructured":"Graham F. Daily briefing: Australia will be first to prescribe these psychedelics as medicines. Nature. 2023. https:\/\/doi.org\/10.1038\/d41586-023-02211-6.","journal-title":"Nature"},{"issue":"45","key":"1013_CR78","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.1523\/JNEUROSCI.1121-22.2022","volume":"42","author":"SF Grieco","year":"2022","unstructured":"Grieco SF, Castr\u00e9n E, Knudsen GM, Kwan AC, Olson DE, Zuo Y, Holmes TC, Xu X. Psychedelics and neural plasticity: therapeutic implications. J Neurosci. 2022;42(45):8439\u201349. https:\/\/doi.org\/10.1523\/JNEUROSCI.1121-22.2022.","journal-title":"J Neurosci"},{"issue":"2","key":"1013_CR79","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV, Chang LC, Jurdi A, Foulkes RK, Iqbal A, Mahoney S, De La Garza JJ, Charney R, Newton DS, T. F., Mathew SJ. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014;17(2):331\u20136. https:\/\/doi.org\/10.1017\/S1461145713001119.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"11","key":"1013_CR80","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/0269881110388326","volume":"25","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. J Psychopharmacol. 2011;25(11):1548\u201361. https:\/\/doi.org\/10.1177\/0269881110388326.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1013_CR81","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","volume":"195","author":"J Hannon","year":"2008","unstructured":"Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res. 2008;195(1):198\u2013213. https:\/\/doi.org\/10.1016\/j.bbr.2008.03.020.","journal-title":"Behav Brain Res"},{"key":"1013_CR82","doi-asserted-by":"publisher","DOI":"10.1177\/2050324516683325","author":"I Hartogsohn","year":"2017","unstructured":"Hartogsohn I. Constructing drug effects: a history of set and setting. Drug Sci Policy Law. 2017. https:\/\/doi.org\/10.1177\/2050324516683325.","journal-title":"Drug Sci Policy Law"},{"issue":"10","key":"1013_CR83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. J Neuropsychiatry Clin Neurosci. 2019;73(10):613\u201327. https:\/\/doi.org\/10.1111\/pcn.12902.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1013_CR84","unstructured":"Healy D. Let them eat PROZAC the unhealthy relationship between the pharmaceutical industry and depression. NYU; 2004."},{"key":"1013_CR221","doi-asserted-by":"crossref","unstructured":"Hearn BG, Brubaker MD, Richardson G. Counselors\u2019 attitudes toward psychedelics and their use in therapy. J Couns Dev. 2022;100(4):364\u2013373.","DOI":"10.1002\/jcad.12429"},{"issue":"5","key":"1013_CR85","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.neuropharm.2006.06.019","volume":"51","author":"V Hern\u00e1ndez-Rabaza","year":"2006","unstructured":"Hern\u00e1ndez-Rabaza V, Dom\u00ednguez-Escrib\u00e0 L, Barcia JA, Rosel JF, Romero FJ, Garc\u00eda-Verdugo JM, Canales JJ. Binge administration of 3,4-methylenedioxymethamphetamine (ecstasy) impairs the survival of neural precursors in adult rat dentate gyrus. Neuropharmacology. 2006;51(5):967\u201373. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.06.019.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1013_CR86","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fct.2009.12.019","volume":"48","author":"T Herraiz","year":"2010","unstructured":"Herraiz T, Gonz\u00e1lez D, Anc\u00edn-Azpilicueta C, Ar\u00e1n VJ, Guill\u00e9n H. \u03b2-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol. 2010;48(3):839\u201345. https:\/\/doi.org\/10.1016\/j.fct.2009.12.019.","journal-title":"Food Chem Toxicol"},{"key":"1013_CR87","doi-asserted-by":"publisher","unstructured":"Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc Nat Acad Sci. 2021;118(17). https:\/\/doi.org\/10.1073\/pnas.2022489118","DOI":"10.1073\/pnas.2022489118"},{"issue":"1","key":"1013_CR88","first-page":"28","volume":"25","author":"ML Hoefle","year":"2001","unstructured":"Hoefle ML, Warner-Lambert PD. The early history of Parke-Davis and Company. Bull History Chemestry. 2001;25(1):28.","journal-title":"Bull History Chemestry"},{"issue":"1","key":"1013_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43. https:\/\/doi.org\/10.1186\/1471-2288-14-43.","journal-title":"BMC Med Res Methodol"},{"key":"1013_CR220","unstructured":"Holman CL. Spirituality for sale an analysis of ayahuasca tourism. Arizona State University; 2010."},{"issue":"2","key":"1013_CR90","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12640-016-9615-7","volume":"30","author":"H Huang","year":"2016","unstructured":"Huang H, Liu C-M, Sun J, Hao T, Xu C-M, Wang D, Wu Y-Q. Ketamine affects the neurogenesis of the hippocampal dentate Gyrus in 7-Day-old rats. Neurotox Res. 2016;30(2):185\u201398. https:\/\/doi.org\/10.1007\/s12640-016-9615-7.","journal-title":"Neurotox Res"},{"key":"1013_CR91","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mehy.2017.01.013","volume":"100","author":"RD Idell","year":"2017","unstructured":"Idell RD, Florova G, Komissarov AA, Shetty S, Girard RBS, Idell S. The fibrinolytic system: a new target for treatment of depression with psychedelics. Med Hypotheses. 2017;100:46\u201353. https:\/\/doi.org\/10.1016\/j.mehy.2017.01.013.","journal-title":"Med Hypotheses"},{"key":"1013_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001747","author":"JPA Ioannidis","year":"2014","unstructured":"Ioannidis JPA. How to make more published Research True. PLoS Med. 2014. https:\/\/doi.org\/10.1371\/journal.pmed.1001747.","journal-title":"PLoS Med"},{"issue":"3","key":"1013_CR93","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/sj.mp.4000712","volume":"5","author":"BL Jacobs","year":"2000","unstructured":"Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000;5(3):262\u20139. https:\/\/doi.org\/10.1038\/sj.mp.4000712.","journal-title":"Mol Psychiatry"},{"issue":"10159","key":"1013_CR94","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I, Abdulkader RS, Abebe Z, Abera SF, Abil OZ, Abraha HN, Abu-Raddad LJ, Abu-Rmeileh NME, Accrombessi MMK, Murray CJL. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7.","journal-title":"Lancet"},{"issue":"10","key":"1013_CR95","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148(10):1301\u20138. https:\/\/doi.org\/10.1176\/ajp.148.10.1301.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1013_CR96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neulet.2008.06.028","volume":"441","author":"S Jha","year":"2008","unstructured":"Jha S, Rajendran R, Fernandes KA, Vaidya VA. 5-HT2A\/2\u00a0C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neurosci Lett. 2008;441(2):210\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.028.","journal-title":"Neurosci Lett"},{"issue":"11","key":"1013_CR97","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1172\/JCI25509","volume":"115","author":"W Jiang","year":"2005","unstructured":"Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005;115(11):3104\u201316. https:\/\/doi.org\/10.1172\/JCI25509.","journal-title":"J Clin Invest"},{"issue":"46","key":"1013_CR98","doi-asserted-by":"publisher","first-page":"19575","DOI":"10.1073\/pnas.0905884106","volume":"106","author":"KA Jones","year":"2009","unstructured":"Jones KA, Srivastava DP, Allen JA, Strachan RT, Roth BL, Penzes P. Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling. Proc Natl Acad Sci USA. 2009;106(46):19575\u201380. https:\/\/doi.org\/10.1073\/pnas.0905884106.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1013_CR99","unstructured":"Journey JD, Bentley TP. Phencyclidine toxicity. StatPearls; 2021."},{"issue":"7","key":"1013_CR100","first-page":"917","volume":"165","author":"H Kalant","year":"2001","unstructured":"Kalant H. The pharmacology and toxicology of ecstasy (MDMA) and related drugs. CMAJ: Can Med Association J = J de l\u2019Association Medicale Canadienne. 2001;165(7):917\u201328.","journal-title":"CMAJ: Can Med Association J = J de l\u2019Association Medicale Canadienne"},{"issue":"4308","key":"1013_CR101","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.887941","volume":"197","author":"M Kaplan","year":"1977","unstructured":"Kaplan M, Hinds J. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science. 1977;197(4308):1092\u20134. https:\/\/doi.org\/10.1126\/science.887941.","journal-title":"Science"},{"issue":"25","key":"1013_CR102","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.2174\/13816128113199990620","volume":"20","author":"L Karila","year":"2014","unstructured":"Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin H-J, Lancon C. Acute and Long-Term effects of Cannabis Use: a review. Curr Pharm Design. 2014;20(25):4112\u20138. https:\/\/doi.org\/10.2174\/13816128113199990620.","journal-title":"Curr Pharm Design"},{"key":"1013_CR103","doi-asserted-by":"publisher","first-page":"112743","DOI":"10.1016\/j.jep.2020.112743","volume":"255","author":"A Katchborian-Neto","year":"2020","unstructured":"Katchborian-Neto A, Santos WT, Nic\u00e1cio KJ, Corr\u00eaa JOA, Murgu M, Martins TMM, Gomes DA, Goes AM, Soares MG, Dias DF, Chagas-Paula DA, Paula ACC. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson\u2019s disease. J Ethnopharmacol. 2020;255:112743. https:\/\/doi.org\/10.1016\/j.jep.2020.112743.","journal-title":"J Ethnopharmacol"},{"key":"1013_CR219","doi-asserted-by":"crossref","unstructured":"Keeler JL, Treasure J, Juruena MF, Kan C, Himmerich H. Ketamine as a treatment for anorexia nervosa: a narrative review. Nutrients. 2021;13(11):4158.","DOI":"10.3390\/nu13114158"},{"issue":"5","key":"1013_CR104","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopsych.2004.06.010","volume":"56","author":"G Keilhoff","year":"2004","unstructured":"Keilhoff G, Bernstein HG, Becker A, Grecksch G, Wolf G. Increased neurogenesis in a rat ketamine model of schizophrenia. Biol Psychiatry. 2004;56(5):317\u201322. https:\/\/doi.org\/10.1016\/j.biopsych.2004.06.010.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1013_CR105","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1034\/j.1399-5618.2002.40101.x","volume":"4","author":"G Kempermann","year":"2002","unstructured":"Kempermann G. Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression 1. Bipolar Disord. 2002;4(1):17\u201333. https:\/\/doi.org\/10.1034\/j.1399-5618.2002.40101.x.","journal-title":"Bipolar Disord"},{"issue":"10","key":"1013_CR106","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn3319","volume":"13","author":"G Kempermann","year":"2012","unstructured":"Kempermann G. New neurons for survival of the fittest. Nat Rev Neurosci. 2012;13(10):727\u201336. https:\/\/doi.org\/10.1038\/nrn3319.","journal-title":"Nat Rev Neurosci"},{"issue":"6997","key":"1013_CR107","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/430311a","volume":"430","author":"DA King","year":"2004","unstructured":"King DA. The scientific impact of nations. Nature. 2004;430(6997):311\u20136. https:\/\/doi.org\/10.1038\/430311a.","journal-title":"Nature"},{"issue":"1","key":"1013_CR108","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2006.07.080","volume":"1113","author":"LJ Kochman","year":"2006","unstructured":"Kochman LJ, dos Santos AA, Fornal CA, Jacobs BL. Despite strong behavioral disruption, \u22069-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Res. 2006;1113(1):86\u201393. https:\/\/doi.org\/10.1016\/j.brainres.2006.07.080.","journal-title":"Brain Res"},{"key":"1013_CR109","doi-asserted-by":"crossref","unstructured":"Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323(5916):934\u2013937.","DOI":"10.1126\/science.1166127"},{"issue":"5","key":"1013_CR110","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0892-0362(03)00091-6","volume":"25","author":"JB Koprich","year":"2003","unstructured":"Koprich JB, Chen E-Y, Kanaan NM, Campbell NG, Kordower JH, Lipton JW. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol. 2003;25(5):509\u201317. https:\/\/doi.org\/10.1016\/S0892-0362(03)00091-6.","journal-title":"Neurotoxicol Teratol"},{"key":"1013_CR111","doi-asserted-by":"crossref","unstructured":"Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation.  J Neurosci Off J Soc Neurosci. 1996.","DOI":"10.1523\/JNEUROSCI.16-06-02027.1996"},{"key":"1013_CR112","doi-asserted-by":"publisher","unstructured":"Labate BC, Cavnar C. (2013). The therapeutic use of Ayahuasca. In The Therapeutic Use of Ayahuasca. https:\/\/doi.org\/10.1007\/978-3-642-40426-9","DOI":"10.1007\/978-3-642-40426-9"},{"key":"1013_CR113","doi-asserted-by":"publisher","unstructured":"Labate BC, Cavnar C. Ayahuasca Shamanism in the Amazon and Beyond. In: Labate BC, Cavnar C, editors. Ayahuasca Shamanism in the Amazon and Beyond. Oxford University Press; 2014. https:\/\/doi.org\/10.1093\/acprof:oso\/9780199341191.001.0001.","DOI":"10.1093\/acprof:oso\/9780199341191.001.0001"},{"issue":"2","key":"1013_CR114","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugpo.2011.06.006","volume":"23","author":"BC Labate","year":"2012","unstructured":"Labate BC, Feeney K. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges. Int J Drug Policy. 2012;23(2):154\u201361. https:\/\/doi.org\/10.1016\/j.drugpo.2011.06.006.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1013_CR115","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1371\/journal.pmed.0020392","volume":"2","author":"JR Lacasse","year":"2005","unstructured":"Lacasse JR, Leo J. Serotonin and depression: a disconnect between the advertisements and the scientific literature. PLoS Med. 2005;2(12):e392. https:\/\/doi.org\/10.1371\/journal.pmed.0020392.","journal-title":"PLoS Med"},{"issue":"12","key":"1013_CR116","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1371\/journal.pbio.0040409","volume":"4","author":"DA Laplagne","year":"2006","unstructured":"Laplagne DA, Esp\u00f3sito MS, Piatti VC, Morgenstern NA, Zhao C, Van Praag H, Gage FH, Schinder AF. Functional convergence of neurons generated in the developing and adult hippocampus. PLoS Biol. 2006;4(12):2349\u201360. https:\/\/doi.org\/10.1371\/journal.pbio.0040409.","journal-title":"PLoS Biol"},{"issue":"3","key":"1013_CR117","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hipo.22221","volume":"24","author":"TT-Y Lee","year":"2014","unstructured":"Lee TT-Y, Wainwright SR, Hill MN, Galea LAM, Gorzalka BB. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization. Hippocampus. 2014;24(3):280\u201392. https:\/\/doi.org\/10.1002\/hipo.22221.","journal-title":"Hippocampus"},{"issue":"5","key":"1013_CR118","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.bbalip.2018.02.001","volume":"1863","author":"E Leishman","year":"2018","unstructured":"Leishman E, Murphy M, Mackie K, Bradshaw HB. \u2206 9 -Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult. Biochim et Biophys Acta (BBA) - Mol Cell Biology Lipids. 2018;1863(5):479\u201392. https:\/\/doi.org\/10.1016\/j.bbalip.2018.02.001.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Biology Lipids"},{"issue":"1","key":"1013_CR119","doi-asserted-by":"publisher","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2015","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol. 2015;18(1):pyu033\u2013033. https:\/\/doi.org\/10.1093\/ijnp\/pyu033.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1013_CR120","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S19617","author":"JP L\u00e9pine","year":"2011","unstructured":"L\u00e9pine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011. https:\/\/doi.org\/10.2147\/NDT.S19617.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5994","key":"1013_CR121","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, Li X-Y, Aghajanian G, Duman RS. mTOR-Dependent synapse formation underlies the Rapid Antidepressant effects of NMDA antagonists. Science. 2010;329(5994):959\u201364. https:\/\/doi.org\/10.1126\/science.1190287.","journal-title":"Science"},{"issue":"7","key":"1013_CR123","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"issue":"1","key":"1013_CR126","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/syn.20275","volume":"60","author":"J Liu","year":"2006","unstructured":"Liu J, Suzuki T, Seki T, Namba T, Tanimura A, Arai H. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. Synapse. 2006;60(1):56\u201368. https:\/\/doi.org\/10.1002\/syn.20275.","journal-title":"Synapse"},{"issue":"11","key":"1013_CR127","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/npp.2013.128","volume":"38","author":"R-J Liu","year":"2013","unstructured":"Liu R-J, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK. GSK-3 inhibition potentiates the Synaptogenic and Antidepressant-Like effects of Subthreshold doses of ketamine. Neuropsychopharmacology. 2013;38(11):2268\u201377. https:\/\/doi.org\/10.1038\/npp.2013.128.","journal-title":"Neuropsychopharmacology"},{"issue":"June","key":"1013_CR125","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.pnpbp.2017.06.012","volume":"79","author":"F Liu","year":"2017","unstructured":"Liu F, Wu J, Gong Y, Wang P, Zhu L, Tong L, Chen X, Ling Y, Huang C. Harmine produces antidepressant-like effects via restoration of astrocytic functions. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(June):258\u201367. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.012.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"14","key":"1013_CR128","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2174\/138161209788168001","volume":"15","author":"F Lopez-Munoz","year":"2009","unstructured":"Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: the history of the Discovery of antidepressants from 1950s until today. Curr Pharm Design. 2009;15(14):1563\u201386. https:\/\/doi.org\/10.2174\/138161209788168001.","journal-title":"Curr Pharm Design"},{"issue":"11","key":"1013_CR129","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Zarandi S, Sood S, Paddy A, Duim MR, Dennis WC, McAllister MY, Ori-McKenney AK, Gray KM, J. A., Olson DE. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23(11):3170\u201382. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.022.","journal-title":"Cell Rep"},{"issue":"10","key":"1013_CR130","doi-asserted-by":"publisher","first-page":"e1002273","DOI":"10.1371\/journal.pbio.1002273","volume":"13","author":"MR Macleod","year":"2015","unstructured":"Macleod MR, McLean L, Kyriakopoulou A, Serghiou A, de Wilde S, Sherratt A, Hirst N, Hemblade T, Bahor R, Nunes-Fonseca Z, Potluru C, Thomson A, Baginskitae A, Egan J, Vesterinen K, Currie H, Churilov GL, Howells L, D. W., Sena ES. Risk of Bias in reports of in vivo research: a focus for improvement. PLoS Biol. 2015;13(10):e1002273. https:\/\/doi.org\/10.1371\/journal.pbio.1002273.","journal-title":"PLoS Biol"},{"issue":"3","key":"1013_CR131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1254\/jphs.FP0061424","volume":"103","author":"K Maeda","year":"2007","unstructured":"Maeda K, Sugino H, Hirose T, Kitagawa H, Nagai T, Mizoguchi H, Takuma K, Yamada K. Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine. J Pharmacol Sci. 2007;103(3):299\u2013308. https:\/\/doi.org\/10.1254\/jphs.FP0061424.","journal-title":"J Pharmacol Sci"},{"issue":"May","key":"1013_CR132","doi-asserted-by":"publisher","first-page":"107467","DOI":"10.1016\/j.nlm.2021.107467","volume":"183","author":"I Magaraggia","year":"2021","unstructured":"Magaraggia I, Kuiperes Z, Schreiber R. Improving cognitive functioning in major depressive disorder with psychedelics: a dimensional approach. Neurobiol Learn Mem. 2021;183(May):107467. https:\/\/doi.org\/10.1016\/j.nlm.2021.107467.","journal-title":"Neurobiol Learn Mem"},{"issue":"6","key":"1013_CR133","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00702-017-1706-y","volume":"124","author":"Z Marinova","year":"2017","unstructured":"Marinova Z, Walitza S, Gr\u00fcnblatt E. The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension. J Neural Transm. 2017;124(6):749\u201359. https:\/\/doi.org\/10.1007\/s00702-017-1706-y.","journal-title":"J Neural Transm"},{"issue":"6\u20137","key":"1013_CR134","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0024-3205(99)00281-7","volume":"65","author":"BR Martin","year":"1999","unstructured":"Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sci. 1999;65(6\u20137):573\u201395. https:\/\/doi.org\/10.1016\/S0024-3205(99)00281-7.","journal-title":"Life Sci"},{"issue":"MAR","key":"1013_CR135","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fphar.2019.00193","volume":"10","author":"S Marton","year":"2019","unstructured":"Marton S, Gonz\u00e1lez B, Rodr\u00edguez-Bottero S, Miquel E, Mart\u00ednez-Palma L, Pazos M, Pedro Prieto J, Rodr\u00edguez P, Sames D, Seoane G, Scorza C, Cassina P, Carrera I. Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits. Front Pharmacol. 2019;10(MAR):193. https:\/\/doi.org\/10.3389\/fphar.2019.00193.","journal-title":"Front Pharmacol"},{"key":"1013_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.12.023","author":"DS Mathai","year":"2020","unstructured":"Mathai DS, Meyer MJ, Storch EA, Kosten TR. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: a systematic review. J Affect Disord. 2020. https:\/\/doi.org\/10.1016\/j.jad.2019.12.023.","journal-title":"J Affect Disord"},{"issue":"2","key":"1013_CR137","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00213-019-05369-y","volume":"237","author":"J Matheson","year":"2020","unstructured":"Matheson J, Sproule B, Di Ciano P, Fares A, Le Foll B, Mann RE, Brands B. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults. Psychopharmacology. 2020;237(2):305\u201316. https:\/\/doi.org\/10.1007\/s00213-019-05369-y.","journal-title":"Psychopharmacology"},{"key":"1013_CR224","doi-asserted-by":"crossref","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561\u2013564.","DOI":"10.1038\/346561a0"},{"issue":"11","key":"1013_CR138","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/josh.12950","volume":"90","author":"L Matteau-Pelletier","year":"2020","unstructured":"Matteau-Pelletier L, B\u00e9langer RE, Leatherdale S, Desbiens F, Haddad S. Sex-related differences in adolescent Cannabis Use: influences of School Context and School Connectedness. J Sch Health. 2020;90(11):878\u201386. https:\/\/doi.org\/10.1111\/josh.12950.","journal-title":"J Sch Health"},{"issue":"2","key":"1013_CR139","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GHN, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and \u03b2-carboline constituents of Ayahuasca. J Ethnopharmacol. 1984;10(2):195\u2013223. https:\/\/doi.org\/10.1016\/0378-8741(84)90003-5.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1013_CR141","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam R, Parker LA. The endocannabinoid system and the brain. Ann Rev Psychol. 2013;64(1):21\u201347. https:\/\/doi.org\/10.1146\/annurev-psych-113011-143739.","journal-title":"Ann Rev Psychol"},{"issue":"9","key":"1013_CR140","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/BF01959156","volume":"44","author":"R Mechoulam","year":"1988","unstructured":"Mechoulam R, Feigenbaum JJ, Lander N, Segal M, J\u00e4rbe TUC, Hiltunen AJ, Consroe P. Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia. 1988;44(9):762\u20134. https:\/\/doi.org\/10.1007\/BF01959156.","journal-title":"Experientia"},{"issue":"February","key":"1013_CR142","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.conb.2014.08.012.THE","volume":"0","author":"BR Miller","year":"2015","unstructured":"Miller BR, Hen R. The current state of the neurogenic theory of depression and anxiety. Curr Opinions Neurobiol. 2015;0(February):51\u20138. https:\/\/doi.org\/10.1016\/j.conb.2014.08.012.THE.","journal-title":"Curr Opinions Neurobiol"},{"issue":"9","key":"1013_CR143","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology. 2019;236(9):2735\u201345. https:\/\/doi.org\/10.1007\/s00213-019-05249-5.","journal-title":"Psychopharmacology"},{"key":"1013_CR144","doi-asserted-by":"publisher","unstructured":"Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA, Alonso-Gil S, Sanz-SanCristobal M, Riba J, Perez-Castillo A. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiatr. 2020;10(1). https:\/\/doi.org\/10.1038\/s41398-020-01011-0.","DOI":"10.1038\/s41398-020-01011-0"},{"issue":"1","key":"1013_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05407-9","volume":"7","author":"JA Morales-Garc\u00eda","year":"2017","unstructured":"Morales-Garc\u00eda JA, De La Fuente Revenga M, Alonso-Gil S, Rodr\u00edguez-Franco MI, Feilding A, Perez-Castillo A, Riba J. The alkaloids of Banisteriopsis caapi, the plant source of the amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro. Sci Rep. 2017;7(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-017-05407-9.","journal-title":"Sci Rep"},{"key":"1013_CR146","doi-asserted-by":"publisher","unstructured":"Moulin TC, Amaral OB. Using collaboration networks to identify authorship dependence in meta-analysis results. Res Synthesis Methods. 2020:jrsm.1430. https:\/\/doi.org\/10.1002\/jrsm.1430","DOI":"10.1002\/jrsm.1430"},{"issue":"1","key":"1013_CR149","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12993-020-00168-4","volume":"16","author":"TC Moulin","year":"2020","unstructured":"Moulin TC, Schi\u00f6th HB. Excitability, synaptic balance, and addiction: the homeostatic dynamics of ionotropic glutamatergic receptors in VTA after cocaine exposure. Behav Brain Funct. 2020;16(1):6. https:\/\/doi.org\/10.1186\/s12993-020-00168-4.","journal-title":"Behav Brain Funct"},{"key":"1013_CR148","doi-asserted-by":"publisher","unstructured":"Moulin TC, Ray\u00eae D, Williams MJ, Schi\u00f6th HB. The synaptic scaling literature: a systematic review of methodologies and quality of reporting. Front Cell Neurosci. 2020;14. https:\/\/doi.org\/10.3389\/fncel.2020.00164.","DOI":"10.3389\/fncel.2020.00164"},{"issue":"1","key":"1013_CR147","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1673-5374.314283","volume":"17","author":"TC Moulin","year":"2022","unstructured":"Moulin TC, Ray\u00eae D, Schi\u00f6th HB. Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies. Neural Regeneration Res. 2022;17(1):20\u20134. https:\/\/doi.org\/10.4103\/1673-5374.314283.","journal-title":"Neural Regeneration Res"},{"issue":"November","key":"1013_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2021.710338","volume":"12","author":"S-A Muscat","year":"2021","unstructured":"Muscat S-A, Hartelius G, Crouch CR, Morin KW. An Integrative Approach to ketamine therapy may enhance multiple dimensions of efficacy: improving therapeutic outcomes with treatment resistant depression. Front Psychiatry. 2021;12(November):1\u201320. https:\/\/doi.org\/10.3389\/fpsyt.2021.710338.","journal-title":"Front Psychiatry"},{"issue":"April","key":"1013_CR151","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","volume":"258","author":"S Muttoni","year":"2019","unstructured":"Muttoni S, Ardissino M, John C. Classical psychedelics for the treatment of depression and anxiety: a systematic review. J Affect Disord. 2019;258(April):11\u201324. https:\/\/doi.org\/10.1016\/j.jad.2019.07.076.","journal-title":"J Affect Disord"},{"issue":"2\u20133","key":"1013_CR152","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","volume":"559","author":"F Nagai","year":"2007","unstructured":"Nagai F, Nonaka R, Satoh H, Kamimura K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol. 2007;559(2\u20133):132\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.075.","journal-title":"Eur J Pharmacol"},{"issue":"6450","key":"1013_CR153","doi-asserted-by":"publisher","first-page":"eaaw7317","DOI":"10.1126\/science.aaw7317","volume":"365","author":"S Naqvi","year":"2019","unstructured":"Naqvi S, Godfrey AK, Hughes JF, Goodheart ML, Mitchell RN, Page DC. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals. Science. 2019;365(6450):eaaw7317. https:\/\/doi.org\/10.1126\/science.aaw7317.","journal-title":"Science"},{"issue":"2","key":"1013_CR154","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0378-8741(79)90003-5","volume":"1","author":"P Naranjo","year":"1979","unstructured":"Naranjo P. Hallucinogenic plant use and related indigenous belief systems in the Ecuadorian amazon. J Ethnopharmacol. 1979;1(2):121\u201345. https:\/\/doi.org\/10.1016\/0378-8741(79)90003-5.","journal-title":"J Ethnopharmacol"},{"key":"1013_CR155","doi-asserted-by":"publisher","unstructured":"Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron. 2002;34(1):13\u201325. https:\/\/doi.org\/10.1016\/S0896-6273(02)00653-0","DOI":"10.1016\/S0896-6273(02)00653-0"},{"issue":"4","key":"1013_CR156","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","volume":"18","author":"DE Nichols","year":"1986","unstructured":"Nichols DE. Differences between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. J Psychoactive Drugs. 1986;18(4):305\u201313. https:\/\/doi.org\/10.1080\/02791072.1986.10472362.","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"1013_CR157","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE. Hallucinogens. Pharmacol Ther. 2004;101(2):131\u201381. https:\/\/doi.org\/10.1016\/j.pharmthera.2003.11.002.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1013_CR158","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264\u2013355. https:\/\/doi.org\/10.1124\/pr.115.011478.","journal-title":"Pharmacol Rev"},{"key":"1013_CR159","doi-asserted-by":"publisher","unstructured":"Ninnemann A, Stuart GL, Andersen SM. Convention on psychotropic substances, 1971. encyclopedia of drug policy. SAGE Publications, Inc; 2012. https:\/\/doi.org\/10.4135\/9781412976961.n78.","DOI":"10.4135\/9781412976961.n78"},{"key":"1013_CR226","unstructured":"NIDA. MDMA (Ecstasy\/Molly). 2024. Retrieved from: https:\/\/nida.nih.gov\/research-topics\/mdma-ecstasy-molly on 2024, December 3."},{"issue":"2","key":"1013_CR160","doi-asserted-by":"publisher","first-page":"237","DOI":"10.14670\/HH-25.237","volume":"25","author":"T Numakawa","year":"2010","unstructured":"Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. BDNF function and intracellular signaling in neurons. Histol Histopathol. 2010;25(2):237\u201358. https:\/\/doi.org\/10.14670\/HH-25.237.","journal-title":"Histol Histopathol"},{"key":"1013_CR161","unstructured":"OHAT. OHAT risk of bias rating tool for human and animal studies organization of this document indirectness, timing, and other factors related to risk of bias. 2015:1\u201337."},{"key":"1013_CR162","doi-asserted-by":"publisher","first-page":"117906951880050","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson DE. Psychoplastogens: a Promising Class of plasticity-promoting neurotherapeutics. J Experimental Neurosci. 2018;12:117906951880050. https:\/\/doi.org\/10.1177\/1179069518800508.","journal-title":"J Experimental Neurosci"},{"issue":"4","key":"1013_CR163","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000100778","volume":"54","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES. Neuropsychobiological evidence for the Functional Presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology. 2006;54(4):231\u201346. https:\/\/doi.org\/10.1159\/000100778.","journal-title":"Neuropsychobiology"},{"key":"1013_CR164","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1957.tb40738.x","author":"H Osmond","year":"1957","unstructured":"Osmond H, REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS. Ann N Y Acad Sci. 1957;66(3):418\u201334. https:\/\/doi.org\/10.1111\/j.1749-6632.1957.tb40738.x. A."},{"issue":"5","key":"1013_CR165","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/17425255.2020.1749262","volume":"16","author":"E Papaseit","year":"2020","unstructured":"Papaseit E, P\u00e9rez-Ma\u00f1\u00e1 C, Torrens M, Farr\u00e9 A, Poyatos L, Hladun O, Sanvisens A, Muga R, Farr\u00e9 M. MDMA interactions with pharmaceuticals and drugs of abuse. Expert Opin Drug Metab Toxicol. 2020;16(5):357\u201369. https:\/\/doi.org\/10.1080\/17425255.2020.1749262.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"1013_CR166","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/add.14234","volume":"113","author":"A Peacock","year":"2018","unstructured":"Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, Ali R, Gowing L, Marsden J, Ferrari AJ, Grebely J, Farrell M, Degenhardt L. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905\u201326. https:\/\/doi.org\/10.1111\/add.14234.","journal-title":"Addiction"},{"key":"1013_CR167","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","volume":"30","author":"RG Pertwee","year":"2006","unstructured":"Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes. 2006;30:S13\u20138. https:\/\/doi.org\/10.1038\/sj.ijo.0803272.","journal-title":"Int J Obes"},{"issue":"03","key":"1013_CR168","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1055\/a-1291-8079","volume":"54","author":"M Petermann","year":"2021","unstructured":"Petermann M, Kronenberg G, Mosienko V, Bader M, Alenina N, Hellweg R, Klempin F. Alterations in BDNF protein concentrations in the Hippocampus do not explain the Pro-neurogenic Effect of Citalopram on Adult Neurogenesis. Pharmacopsychiatry. 2021;54(03):101\u20135. https:\/\/doi.org\/10.1055\/a-1291-8079.","journal-title":"Pharmacopsychiatry"},{"issue":"9","key":"1013_CR169","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1517\/13543784.2014.918951","volume":"23","author":"B Pochwat","year":"2014","unstructured":"Pochwat B, Pa\u0142ucha-Poniewiera A, Szewczyk B, Pilc A, Nowak G. NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin Investig Drugs. 2014;23(9):1181\u201392. https:\/\/doi.org\/10.1517\/13543784.2014.918951.","journal-title":"Expert Opin Investig Drugs"},{"issue":"7","key":"1013_CR170","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1111\/bph.15394","volume":"178","author":"N Poulia","year":"2021","unstructured":"Poulia N, Delis F, Brakatselos C, Polissidis A, Koutmani Y, Kokras N, Dalla C, Politis PK, Antoniou K. Detrimental effects of adolescent escalating low-dose \u22069-tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats. Br J Pharmacol. 2021;178(7):1722\u201336. https:\/\/doi.org\/10.1111\/bph.15394.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1013_CR171","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/bdrb.20166","volume":"83","author":"D Psychoyos","year":"2008","unstructured":"Psychoyos D, Hungund B, Cooper T, Finnell RH. A cannabinoid analogue of \u22069-tetrahydrocannabinol disrupts neural development in chick. Birth Defects Res Part B - Dev Reproductive Toxicol. 2008;83(5):477\u201388. https:\/\/doi.org\/10.1002\/bdrb.20166.","journal-title":"Birth Defects Res Part B - Dev Reproductive Toxicol"},{"issue":"2\u20133","key":"1013_CR172","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuropharm.2010.09.003","volume":"60","author":"N Realini","year":"2011","unstructured":"Realini N, Vigano\u2019 D, Guidali C, Zamberletti E, Rubino T, Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology. 2011;60(2\u20133):235\u201343. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.09.003.","journal-title":"Neuropharmacology"},{"key":"1013_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.09.012","volume":"81","author":"S Reiche","year":"2018","unstructured":"Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Maji\u0107 T. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review. Prog Neuro-psychopharmacol Biol Psychiatry. 2018;81:1\u201310. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.09.012.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"29","key":"1013_CR174","doi-asserted-by":"publisher","first-page":"eabg2286","DOI":"10.1126\/sciadv.abg2286","volume":"7","author":"G Ren","year":"2021","unstructured":"Ren G, Zhang X, Li Y, Ridout K, Serrano-Serrano ML, Yang Y, Liu A, Ravikanth G, Nawaz MA, Mumtaz AS, Salamin N, Fumagalli L. Large-scale whole-genome resequencing unravels the domestication history of Cannabis sativa. Sci Adv. 2021;7(29):eabg2286. https:\/\/doi.org\/10.1126\/sciadv.abg2286.","journal-title":"Sci Adv"},{"key":"1013_CR175","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neuropharm.2015.10.016","volume":"101","author":"MS Riga","year":"2016","unstructured":"Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT 1A and 5-HT 2A receptors. Neuropharmacology. 2016;101:370\u20138. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.016.","journal-title":"Neuropharmacology"},{"issue":"2","key":"1013_CR176","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02860772","volume":"26","author":"L Rivier","year":"1972","unstructured":"Rivier L, Lindgren J-E. Ayahuasca, the South American Hallucinogenic drink: an ethnobotanical and Chemical Investigation. Econ Bot. 1972;26(2):101\u201329.","journal-title":"Econ Bot"},{"issue":"3","key":"1013_CR177","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archpsyc.1973.04200030093015","volume":"29","author":"DS Robinson","year":"1973","unstructured":"Robinson DS. The Monoamine Oxidase Inhibitor, Phenelzine, in the treatment of Depressive-Anxiety States. Arch Gen Psychiatry. 1973;29(3):407. https:\/\/doi.org\/10.1001\/archpsyc.1973.04200030093015.","journal-title":"Arch Gen Psychiatry"},{"issue":"14","key":"1013_CR178","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/138161209788168029","volume":"15","author":"F Rodriguez Bambico","year":"2009","unstructured":"Rodriguez Bambico F, Duranti A, Tontini A, Tarzia G, Gobbi G. Endocannabinoids in the treatment of Mood disorders: evidence from animal models. Curr Pharm Design. 2009;15(14):1623\u201346. https:\/\/doi.org\/10.2174\/138161209788168029.","journal-title":"Curr Pharm Design"},{"issue":"11","key":"1013_CR179","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","volume":"33","author":"T Rubino","year":"2008","unstructured":"Rubino T, Vigano\u2019 D, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C, Cherubino F, Romualdi P, Candeletti S, Sala M, Parolaro D. Chronic \u22069-Tetrahydrocannabinol during adolescence provokes sex-dependent changes in the Emotional Profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008;33(11):2760\u201371. https:\/\/doi.org\/10.1038\/sj.npp.1301664.","journal-title":"Neuropsychopharmacology"},{"key":"1013_CR180","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJH Rucker","year":"2018","unstructured":"Rucker JJH, Iliff J, Nutt DJ. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology. 2018;142:200\u201318. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.040.","journal-title":"Neuropharmacology"},{"issue":"48","key":"1013_CR181","doi-asserted-by":"publisher","first-page":"46645","DOI":"10.1074\/jbc.M206590200","volume":"277","author":"D Rueda","year":"2002","unstructured":"Rueda D, Navarro B, Mart\u00ednez-Serrano A, Guzm\u00e1n M, Galve-Roperh I. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1\/B-Raf\/ERK pathway. J Biol Chem. 2002;277(48):46645\u201350. https:\/\/doi.org\/10.1074\/jbc.M206590200.","journal-title":"J Biol Chem"},{"key":"1013_CR182","unstructured":"Ruiz P, Strain E. Substance abuse: a comprehensive textbook. In: Lowinson, Ruiz P, editors. Wolters Kluwer. Wolters Kluwer; 2011."},{"issue":"1","key":"1013_CR183","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.2271","volume":"28","author":"JK Rybakowski","year":"2013","unstructured":"Rybakowski JK, Permoda-Osip A, Skibinska M, Adamski R, Bartkowska-Sniatkowska A. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Human Psychopharmacol. 2013;28(1):87\u201390. https:\/\/doi.org\/10.1002\/hup.2271.","journal-title":"Human Psychopharmacol"},{"key":"1013_CR184","doi-asserted-by":"publisher","unstructured":"Saengsawang W, Rasenick MM. (2016). G Protein-Coupled Receptors. In Encyclopedia of Cell Biology (pp. 51\u201355). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-12-394447-4.30004-9","DOI":"10.1016\/B978-0-12-394447-4.30004-9"},{"key":"1013_CR185","doi-asserted-by":"publisher","unstructured":"Sanches M, Quevedo J, Soares JC. New agents and perspectives in the pharmacological treatment of major depressive disorder. In: Progress in neuro-psychopharmacology and biological psychiatry, Vol. 106. 2021; p. 9. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110157","DOI":"10.1016\/j.pnpbp.2020.110157"},{"key":"1013_CR186","doi-asserted-by":"publisher","unstructured":"Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther. 2019;204. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107402.","DOI":"10.1016\/j.pharmthera.2019.107402"},{"issue":"1","key":"1013_CR187","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","volume":"88","author":"J Savitz","year":"2009","unstructured":"Savitz J, Lucki I, Drevets WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009;88(1):17\u201331. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.01.009.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"1013_CR188","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1017\/S1461145712001447","volume":"16","author":"TL Schaefer","year":"2013","unstructured":"Schaefer TL, Grace CE, Braun AA, Amos-Kroohs RM, Graham DL, Skelton MR, Williams MT, Vorhees CV. Cognitive impairments from developmental exposure to serotonergic drugs: Citalopram and MDMA. Int J Neuropsychopharmacol. 2013;16(6):1383\u201394. https:\/\/doi.org\/10.1017\/S1461145712001447.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1013_CR189","doi-asserted-by":"publisher","unstructured":"Schiavone S, Morgese MG, Bove M, Colia AL, Maffione AB, Tucci P, Trabace L, Cuomo V. Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice. Progress Neuro-Psychopharmacology Biol Psychiatr. 2020;96(January 2019). https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109750","DOI":"10.1016\/j.pnpbp.2019.109750"},{"key":"1013_CR190","doi-asserted-by":"publisher","unstructured":"Sessa B. MDMA and PTSD treatment: PTSD: From novel pathophysiology to innovative therapeutics. Neuroscience Lett. 2017. https:\/\/doi.org\/10.1016\/j.neulet.2016.07.004","DOI":"10.1016\/j.neulet.2016.07.004"},{"key":"1013_CR191","doi-asserted-by":"publisher","first-page":"103463","DOI":"10.1016\/j.mcn.2019.103463","volume":"103","author":"C Shum","year":"2020","unstructured":"Shum C, Dutan L, Annuario E, Warre-Cornish K, Taylor SE, Taylor RD, Andreae LC, Buckley NJ, Price J, Bhattacharyya S, Srivastava DP. \u22069-tetrahydrocannabinol and 2-AG decreases neurite outgrowth and differentially affects ERK1\/2 and akt signaling in hiPSC-derived cortical neurons. Mol Cell Neurosci. 2020;103:103463. https:\/\/doi.org\/10.1016\/j.mcn.2019.103463.","journal-title":"Mol Cell Neurosci"},{"key":"1013_CR225","unstructured":"Shulgin AT, Shulgin A. PIHKAL: a chemical love story (Vol. 963009605). Berkeley, CA: Transform Press; 1991"},{"key":"1013_CR192","doi-asserted-by":"publisher","unstructured":"Sial OK, Parise EM, Parise LF, Gnecco T, Bola\u00f1os-Guzm\u00e1n CA. Ketamine: the final frontier or another depressing end? In: Behavioural brain research, Vol. 383. 2020; p. 18. https:\/\/doi.org\/10.1016\/j.bbr.2020.112508","DOI":"10.1016\/j.bbr.2020.112508"},{"issue":"1607","key":"1013_CR193","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","volume":"367","author":"SD Skaper","year":"2012","unstructured":"Skaper SD, Di Marzo V. Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philosophical Trans Royal Soc B: Biol Sci. 2012;367(1607):3193\u2013200. https:\/\/doi.org\/10.1098\/rstb.2012.0313.","journal-title":"Philosophical Trans Royal Soc B: Biol Sci"},{"key":"1013_CR223","doi-asserted-by":"crossref","unstructured":"Sorrells SF, Paredes MF, Cebrian-Silla A, Sandoval K, Qi D, Kelley KW, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555(7696):377\u2013381.","DOI":"10.1038\/nature25975"},{"issue":"5","key":"1013_CR194","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/adb.12394","volume":"22","author":"N Stanslowsky","year":"2017","unstructured":"Stanslowsky N, Jahn K, Venneri A, Naujock M, Haase A, Martin U, Frieling H, Wegner F. Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells. Addict Biol. 2017;22(5):1329\u201342. https:\/\/doi.org\/10.1111\/adb.12394.","journal-title":"Addict Biol"},{"key":"1013_CR195","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2013.12.034","volume":"1548","author":"RWJ Steel","year":"2014","unstructured":"Steel RWJ, Miller JH, Sim DA, Day DJ. Delta-9-tetrahydrocannabinol disrupts hippocampal neuroplasticity and neurogenesis in trained, but not untrained adolescent Sprague-Dawley rats. Brain Res. 2014;1548:12\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2013.12.034.","journal-title":"Brain Res"},{"issue":"2","key":"1013_CR196","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12640-017-9806-x","volume":"33","author":"NA Suliman","year":"2018","unstructured":"Suliman NA, Taib CNM, Moklas MAM, Basir R. Delta-9-Tetrahydrocannabinol (\u22069-THC) induce neurogenesis and improve cognitive performances of male Sprague Dawley rats. Neurotox Res. 2018;33(2):402\u201311. https:\/\/doi.org\/10.1007\/s12640-017-9806-x.","journal-title":"Neurotox Res"},{"issue":"3","key":"1013_CR197","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jep.2014.02.018","volume":"153","author":"G Svobodny","year":"2014","unstructured":"Svobodny G. The internationalization of Ayahuasca. J Ethnopharmacol. 2014;153(3):933. https:\/\/doi.org\/10.1016\/j.jep.2014.02.018.","journal-title":"J Ethnopharmacol"},{"issue":"July","key":"1013_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00358","volume":"6","author":"A Szabo","year":"2015","unstructured":"Szabo A. Psychedelics and Immunomodulation: Novel approaches and Therapeutic opportunities. Front Immunol. 2015;6(July):1\u201311. https:\/\/doi.org\/10.3389\/fimmu.2015.00358.","journal-title":"Front Immunol"},{"issue":"9","key":"1013_CR199","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/syn.20660","volume":"63","author":"A Tanimura","year":"2009","unstructured":"Tanimura A, Liu J, Namba T, Seki T, Matsubara Y, Itoh M, Suzuki T, Arai H. Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats. Synapse. 2009;63(9):729\u201336. https:\/\/doi.org\/10.1002\/syn.20660.","journal-title":"Synapse"},{"issue":"4\u20135","key":"1013_CR201","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.physbeh.2008.12.013","volume":"96","author":"VB Thompson","year":"2009","unstructured":"Thompson VB, Heiman J, Chambers JB, Benoit SC, Buesing WR, Norman MK, Norman AB, Lipton JW. Long-term behavioral consequences of prenatal MDMA exposure. Physiol Behav. 2009;96(4\u20135):593\u2013601. https:\/\/doi.org\/10.1016\/j.physbeh.2008.12.013.","journal-title":"Physiol Behav"},{"issue":"1","key":"1013_CR200","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ntt.2011.09.005","volume":"34","author":"VBB Thompson","year":"2012","unstructured":"Thompson VBB, Koprich JBB, Chen EYY, Kordower JHH, Terpstra BTT, Lipton JWW. Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat. Neurotoxicol Teratol. 2012;34(1):206\u201313. https:\/\/doi.org\/10.1016\/j.ntt.2011.09.005.","journal-title":"Neurotoxicol Teratol"},{"issue":"6","key":"1013_CR202","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/npp.2011.324","volume":"37","author":"K Toriumi","year":"2012","unstructured":"Toriumi K, Mouri A, Narusawa S, Aoyama Y, Ikawa N, Lu L, Nagai T, Mamiya T, Kim H-C, Nabeshima T. Prenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the Prefrontal Cortex. Neuropsychopharmacology. 2012;37(6):1387\u201396. https:\/\/doi.org\/10.1038\/npp.2011.324.","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"1013_CR203","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010;11(9):642\u201351. https:\/\/doi.org\/10.1038\/nrn2884.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"1013_CR204","doi-asserted-by":"publisher","first-page":"e2006930","DOI":"10.1371\/journal.pbio.2006930","volume":"16","author":"JD Wallach","year":"2018","unstructured":"Wallach JD, Boyack KW, Ioannidis JPA. Reproducible research practices, transparency, and open access data in the biomedical literature, 2015\u20132017. PLoS Biol. 2018;16(11):e2006930. https:\/\/doi.org\/10.1371\/journal.pbio.2006930.","journal-title":"PLoS Biol"},{"issue":"1","key":"1013_CR205","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","volume":"8","author":"Z Walsh","year":"2022","unstructured":"Walsh Z, Mollaahmetoglu OM, Rootman J, Golsof S, Keeler J, Marsh B, Nutt DJ, Morgan CJA. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 2022;8(1):e19. https:\/\/doi.org\/10.1192\/bjo.2021.1061.","journal-title":"BJPsych Open"},{"key":"1013_CR206","doi-asserted-by":"publisher","first-page":"112780","DOI":"10.1016\/j.bbr.2020.112780","volume":"393","author":"W Wankhar","year":"2020","unstructured":"Wankhar W, Syiem D, Pakyntein CL, Thabah D, Sunn SE. Effect of 5-HT2C receptor agonist and antagonist on chronic unpredictable stress (CUS) - mediated anxiety and depression in adolescent Wistar albino rat: implicating serotonin and mitochondrial ETC-I function in serotonergic neurotransmission. Behav Brain Res. 2020;393:112780. https:\/\/doi.org\/10.1016\/j.bbr.2020.112780.","journal-title":"Behav Brain Res"},{"key":"1013_CR207","doi-asserted-by":"publisher","unstructured":"WHO. Depression, a global public health concern. WHO Department Mental Health Subst Abuse. 2012:1\u20138. https:\/\/doi.org\/10.1007\/978-3-642-11688-9_20.","DOI":"10.1007\/978-3-642-11688-9_20"},{"key":"1013_CR208","doi-asserted-by":"crossref","unstructured":"Williams GV, Rao SG, Goldman-Rakic PS. The physiological role of 5-HT 2A receptors in working memory; 2002.","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002"},{"issue":"12","key":"1013_CR209","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3949\/ccjm.77a.09103","volume":"77","author":"M Wimbiscus","year":"2010","unstructured":"Wimbiscus M, Kostenko O, Malone D. MAO inhibitors: risks, benefits, and lore. Cleve Clin J Med. 2010;77(12):859\u201382. https:\/\/doi.org\/10.3949\/ccjm.77a.09103.","journal-title":"Cleve Clin J Med"},{"issue":"October 2019","key":"1013_CR210","doi-asserted-by":"publisher","first-page":"113175","DOI":"10.1016\/j.expneurol.2020.113175","volume":"326","author":"J Winne","year":"2020","unstructured":"Winne J, Boerner BC, Malfatti T, Brisa E, Doerl J, Nogueira I, Le\u00e3o KE, Le\u00e3o RN. Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT. Exp Neurol. 2020;326(October 2019):113175. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113175.","journal-title":"Exp Neurol"},{"issue":"5","key":"1013_CR211","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/35072566","volume":"2","author":"ML Wong","year":"2001","unstructured":"Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci. 2001;2(5):343\u201351. https:\/\/doi.org\/10.1038\/35072566.","journal-title":"Nat Rev Neurosci"},{"key":"1013_CR222","doi-asserted-by":"crossref","unstructured":"Worrell SD, Gould TJ. Therapeutic potential of ketamine for alcohol use disorder. Neurosci Biobehav Rev. 2021;126:573\u2013589.","DOI":"10.1016\/j.neubiorev.2021.05.006"},{"issue":"June 2021","key":"1013_CR122","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jad.2021.09.041","volume":"296","author":"N X Li","year":"2022","unstructured":"Li NX, R Hu Y, N Chen W, Zhang B. Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis. J Affect Disord. 2022;296(June 2021):26\u201334. https:\/\/doi.org\/10.1016\/j.jad.2021.09.041.","journal-title":"J Affect Disord"},{"issue":"10","key":"1013_CR212","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/mp.2017.239","volume":"23","author":"N Yao","year":"2018","unstructured":"Yao N, Skiteva O, Zhang X, Svenningsson P, Chergui K. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit. Mol Psychiatry. 2018;23(10):2066\u201377. https:\/\/doi.org\/10.1038\/mp.2017.239.","journal-title":"Mol Psychiatry"},{"key":"1013_CR213","doi-asserted-by":"publisher","DOI":"10.2174\/1871527315666151111124402","author":"T-F Yuan","year":"2015","unstructured":"Yuan T-F, Paes F, Arias-Carri\u00f3n O, Ferreira Rocha N, de S\u00e1 Filho A, Machado S. Neural mechanisms of Exercise: Anti-depression, Neurogenesis, and Serotonin Signaling. CNS Neurol Disorders - Drug Targets. 2015. https:\/\/doi.org\/10.2174\/1871527315666151111124402.","journal-title":"CNS Neurol Disorders - Drug Targets"},{"issue":"7604","key":"1013_CR214","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KSS, Fang Y, Huang X-P, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA Jr, Gould TD. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533(7604):481\u20136. https:\/\/doi.org\/10.1038\/nature17998.","journal-title":"Nature"},{"issue":"2","key":"1013_CR215","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuropharm.2009.04.017","volume":"57","author":"F Zhang","year":"2009","unstructured":"Zhang F, Challapalli SC, Smith PJW. Cannabinoid CB1 receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca2\u2009+\u2009influx in an in vitro model of diabetic neuropathy. Neuropharmacology. 2009;57(2):88\u201396. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.04.017.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1013_CR216","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1038\/srep19581","volume":"6","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Yu Y, Huang XF. Olanzapine prevents the PCP-induced reduction in the Neurite Outgrowth of Prefrontal cortical neurons via NRG1. Sci Rep. 2016;6(1):19581. https:\/\/doi.org\/10.1038\/srep19581.","journal-title":"Sci Rep"},{"issue":"4","key":"1013_CR217","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jnr.1160","volume":"65","author":"D Zhou","year":"2001","unstructured":"Zhou D, Song ZH. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells. J Neurosci Res. 2001;65(4):346\u201353. https:\/\/doi.org\/10.1002\/jnr.1160.","journal-title":"J Neurosci Res"},{"key":"1013_CR218","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbr.2018.05.003","volume":"349","author":"D Zuo","year":"2018","unstructured":"Zuo D, Liu Y, Liu Z, Cui J, Zhou X, Liu Y, Li Z, Wu Y. Alcohol aggravates ketamine-induced behavioral, morphological and neurochemical alterations in adolescent rats: the involvement of CREB-related pathways. Behav Brain Res. 2018;349:80\u201390. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.003.","journal-title":"Behav Brain Res"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-024-01013-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-01013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T07:04:19Z","timestamp":1734591859000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-01013-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":226,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1186\/s10020-024-01013-4","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}